GERN GERON
Health Care · Russell 2000
Next earnings: not announced yet
What 8 analyst firms say about GERON: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
7 rated views · 8 analyst/firm records · 8 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (2)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (2)
Recent analyst activity · last 90 days
Our tracked history has 4 reports on GERN from 3 analyst firms in the last 90 days (8 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it and 1 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Needham lowered its target from $4.00 (set 6 May 2026) to $2.50 on 28 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Goldman Sachs | Corinne Johnson | Sell | 26 Feb 2026 | 1.00 USD |
| H.C. Wainwright | Emily Bodnar | Hold | 13 Jul 2026 | — |
| Needham | Gil Blum | Buy | 28 Oct 2026 | 2.50 USD |
| TD Cowen | Tara Bancroft | Buy | 29 Jan 2026 | 3.00 USD |
| UBS | Unnamed analyst | Hold | 9 Dec 2025 | — |
| Wedbush | Robert Driscoll | Buy | 28 Oct 2026 | 5.00 USD |
| Weiss Ratings | Unnamed analyst | — | 21 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:15 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.